Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Dec;66(12):7159-67.
doi: 10.1128/JVI.66.12.7159-7167.1992.

Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines

L Buonaguro  1 , G Barillari, H K Chang, C A Bohan, V Kao, R Morgan, R C Gallo, B Ensoli
Affiliations

Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines

L Buonaguro et al. J Virol. 1992 Dec.

Abstract

Increased levels of inflammatory cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and IL-6, have been detected in specimens from human immunodeficiency virus type 1 (HIV-1)-infected individuals. Here we demonstrate that HIV-1 activates the expression of TNF but not of IL-1 and IL-6 in acutely and chronically infected T cells. The increase in TNF gene expression is due to activation of the TNF promoter by the viral gene product Tat. Transactivation of TNF gene expression requires the product of the first exon of the tat gene and is cell type independent. T cells chronically infected with pol-defective HIV-1 provirus constitutively express both Tat and TNF at levels significantly higher (fivefold) than those seen in control cells, and treatment with phorbol myristate acetate greatly enhances Tat expression and TNF production. As TNF can increase the production of IL-1 and IL-6 and these inflammatory cytokines all enhance HIV-1 gene expression and affect the immune, vascular, and central nervous systems, the activation of TNF by Tat may be part of a complex pathway in which HIV-1 uses viral products and host factors to increase its own expression and infectivity and to induce disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Immunol. 1990 Jan 15;144(2):480-4 - PubMed
    1. J Exp Med. 1990 Jul 1;172(1):121-9 - PubMed
    1. Cell. 1986 Mar 28;44(6):941-7 - PubMed
    1. J Immunol. 1989 Jan 15;142(2):431-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jan;86(2):621-5 - PubMed

MeSH terms